By | Science | 08-Nov-2025 18:02:56
In a small clinic in rural Bihar, a father once cradled his breathless young son while the lone doctor guessed at pneumonia without any diagnostic tool to confirm it. The nearest testing centre was hours away.
For Tunir Sahoo, then a young student observing the scene, that moment of helplessness
would become the spark that redefined his life—and potentially India’s rural
healthcare system.
The 25-year-old IIM-Kashipur graduate has now
won the James Dyson Award India 2025
for JivaScope, a pocket-sized AI
device priced at ₹3,000 that
screens heart and lung diseases without requiring a doctor, electricity, or
internet.
Sahoo grew up far from research labs, studying
in Kolkata and Kharagpur before earning a pharmacy degree in Durgapur and
completing his MBA at IIM Kashipur. It was during fieldwork across rural India
that he realised the extent of a systemic failure—doctors without tools,
patients without access, and diseases going undetected until they turned fatal.
The answer, he decided, lay in radically simple
engineering.
JivaScope went through more than 20 design
cycles, oscillating between accuracy and usability before reaching its
breakthrough. The team integrated IR-guided
placement, ensuring the device automatically positions itself
correctly on the chest, making it intuitive even for first-time users such as
ASHA workers.
The James Dyson Award’s design-first
philosophy pushed the innovation further, compelling the team to merge elegance
with rugged practicality.
Unlike digital stethoscopes or telemedicine
apps, JivaScope works entirely offline.
“In rural India, internet access is unreliable. An online device would exclude
the very communities we wanted to serve,” Sahoo explains.
The team built lightweight AI models that run
on-device, delivering instant, clinical-grade screening results in minutes.
Cost was non-negotiable. “If health workers can’t afford it, the impact is zero,” Sahoo says.
Using off-the-shelf components and lean
hardware, he kept the price around ₹3,000
and is now working to bring it below
₹2,000.
Field trials offered Sahoo his most meaningful
validation.
“One ASHA worker told me, ‘For the first time, I can give my patients an answer
instead of just referring them elsewhere.’”
For Sahoo, this feedback underscored that
innovation is not only about algorithms—it is about dignity, trust, and agency.
Over the next two years, the team plans to
scale JivaScope to more than 10 states, integrate with the eSanjeevani telehealth platform, secure
regulatory approvals, and expand AI training datasets.
The challenge now shifts from creating the
device to integrating it into India’s vast and varied public health systems—a
journey requiring partnerships with state governments, NGOs, and health
missions.
Here, the Dyson Award serves as a catalyst.
“It gives us visibility, credibility, and access to global mentors. It’s
opening doors that make nationwide adoption realistic,” Sahoo says.
JivaScope is a diagnostic tool, but it is also
something deeper—a promise that answers need not be out of reach simply because
a village is. It turns possibility into accessible, affordable reality.
For millions in rural India, that could be the difference between uncertainty and care, between waiting and knowing, between risk and life.